Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564
about
Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agentsIdentification of potent maturation inhibitors against HIV-1 clade CThe role of the third beta strand in gp120 conformation and neutralization sensitivity of the HIV-1 primary isolate DH012A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors.A small-molecule antagonist of virion assembly.HIV entry inhibitors and their potential in HIV therapyNew anti-HIV agents and targets.Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipainBifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptaseGlycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma.Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variantsThe discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV.New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.Proteasome regulators: activators and inhibitors.Escape from human immunodeficiency virus type 1 (HIV-1) entry inhibitors.Betulinic acid-induced cytotoxicity in human breast tumor cell lines MCF-7 and T47D and its modification by tocopherol.Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.Activation and inhibition of the proteasome by betulinic acid and its derivatives.Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.Docking study of HIV-1 reverse transcriptase with phytochemicals.An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.Promiscuous, Multi-Target Lupane-Type Triterpenoids Inhibits Wild Type and Drug Resistant HIV-1 Replication Through the Interference With Several Targets.Fusion/entry inhibitors as therapies for HIV.
P2860
Q24645221-842C6A2B-2397-4D7B-B73F-995FB6126C2DQ28829072-BE84E287-9BE0-49FC-AD8F-C7056B2A9A43Q33953062-06C85195-F99B-45A1-898B-D32CE6EA28C9Q33966639-02E05D89-2DE8-41AC-BAD4-84604D75F156Q34045239-BC99EBBB-0CEE-4ACA-BA53-23A393013B6CQ34489215-1D74CAA1-BF81-4099-B780-950972CC028EQ34595921-E9C2935B-0CE5-493F-9F73-F0342B0CF204Q34944447-0A4AA8B4-0892-4764-8E86-2B0247D325A7Q35023268-4F993978-C2EB-4628-A811-E366D61B6625Q35548195-3170B76C-B90E-409E-95D4-B2FAFD200F13Q35828340-D76B5D36-C063-4708-A862-7B8ABC1DDF89Q35848212-EA1944DB-4396-4F41-8042-D7188826B60DQ35927570-A5CEEC57-047C-4F80-A095-5EE2F3D0B462Q36185528-3F34520F-17EB-49E2-B9AE-43304FB79F52Q36187060-74A46812-30CF-4C0E-BF85-B2B6E6A54008Q36691642-A15A7BDF-47E4-4F22-82AB-2D73DADAFAA3Q37411350-BFC4DD0B-85FD-464C-AC84-7608413E4EE4Q38076139-8BA1B07F-C184-4522-A550-3C37B548D646Q38975694-FB9BB8BA-927C-469D-979A-61D9DC59FBD0Q40063752-E7C3AD51-3F3C-4094-B900-B019816A3654Q40074485-1ADA3F6D-8591-4DC8-8F3C-79654AD752E2Q40750425-D74A6528-D277-4DB8-B642-408BD2A1C5F3Q42682102-0BEAE255-DEA3-401A-BFA3-D87E67796E53Q42732016-4F61B7D1-277C-4E92-94B4-A82417B1AF48Q47575865-BA77DC50-AB18-411F-ADCA-05DB0608B20AQ53688749-8F127657-2200-49BA-9340-E6625B73D4CBQ53853233-E58B11EF-6671-473B-9764-CD94D780DB07
P2860
Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@ast
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@en
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@nl
type
label
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@ast
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@en
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@nl
prefLabel
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@ast
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@en
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@nl
P2093
P2860
P3181
P1476
Role of human immunodeficiency ...... tulinic acid derivative IC9564
@en
P2093
P2860
P3181
P356
10.1128/AAC.45.1.60-66.2001
P407
P577
2001-01-01T00:00:00Z